1. Home
  2. PBYI vs EM Comparison

PBYI vs EM Comparison

Compare PBYI & EM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBYI
  • EM
  • Stock Information
  • Founded
  • PBYI 2010
  • EM 2017
  • Country
  • PBYI United States
  • EM China
  • Employees
  • PBYI N/A
  • EM N/A
  • Industry
  • PBYI Biotechnology: Pharmaceutical Preparations
  • EM Other Consumer Services
  • Sector
  • PBYI Health Care
  • EM Consumer Discretionary
  • Exchange
  • PBYI Nasdaq
  • EM Nasdaq
  • Market Cap
  • PBYI 164.3M
  • EM 289.1M
  • IPO Year
  • PBYI N/A
  • EM 2021
  • Fundamental
  • Price
  • PBYI $3.45
  • EM $1.12
  • Analyst Decision
  • PBYI Strong Buy
  • EM Hold
  • Analyst Count
  • PBYI 1
  • EM 1
  • Target Price
  • PBYI $7.00
  • EM $1.25
  • AVG Volume (30 Days)
  • PBYI 307.3K
  • EM 93.6K
  • Earning Date
  • PBYI 07-31-2025
  • EM 08-21-2025
  • Dividend Yield
  • PBYI N/A
  • EM N/A
  • EPS Growth
  • PBYI 143.51
  • EM N/A
  • EPS
  • PBYI 0.77
  • EM N/A
  • Revenue
  • PBYI $232,709,000.00
  • EM $259,541,587.00
  • Revenue This Year
  • PBYI N/A
  • EM $3.30
  • Revenue Next Year
  • PBYI N/A
  • EM $5.26
  • P/E Ratio
  • PBYI $4.43
  • EM N/A
  • Revenue Growth
  • PBYI 2.68
  • EM N/A
  • 52 Week Low
  • PBYI $2.23
  • EM $0.50
  • 52 Week High
  • PBYI $4.13
  • EM $1.17
  • Technical
  • Relative Strength Index (RSI)
  • PBYI 50.12
  • EM 49.22
  • Support Level
  • PBYI $3.26
  • EM $1.12
  • Resistance Level
  • PBYI $3.68
  • EM $1.16
  • Average True Range (ATR)
  • PBYI 0.12
  • EM 0.03
  • MACD
  • PBYI 0.00
  • EM -0.00
  • Stochastic Oscillator
  • PBYI 52.90
  • EM 16.67

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

About EM Smart Share Global Limited

Smart Share Global Ltd is a consumer tech company providing mobile device charging services through an extensive online and offline network in China. It provides service through power banks, placed in POIs operated by location partners, such as entertainment venues, restaurants, shopping centers, hotels, transportation hubs, and public spaces. Geographically, the company generates revenue from the PRC. The company has two segments, the mobile device charging segment and the PV business segment. The company generates the majority of its revenue from the mobile device charging segment.

Share on Social Networks: